Controlled Dual Growth Factor Delivery From Microparticles Incorporated Within Human Bone Marrow-Derived Mesenchymal Stem Cell Aggregates for Enhanced Bone Tissue Engineering via Endochondral Ossification. [electronic resource]
- Stem cells translational medicine Feb 2016
- 206-17 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
2157-6564
10.5966/sctm.2015-0115 doi
Alkaline Phosphatase--genetics Biomarkers--metabolism Bone Marrow Cells--cytology Bone Morphogenetic Protein 2--metabolism Calcification, Physiologic--drug effects Calcium--metabolism Cell Aggregation Chondrogenesis--drug effects Collagen Type I--genetics Collagen Type II--genetics Delayed-Action Preparations Drug Compounding Durapatite--chemistry Gelatin--chemistry Gene Expression Glycosaminoglycans--metabolism Humans Mesenchymal Stem Cells--cytology Osteocalcin--genetics Osteogenesis--drug effects Osteopontin--genetics Primary Cell Culture Tissue Engineering--methods Transforming Growth Factor beta1--metabolism